Data is not available at this time.
GoHealth, Inc. operates as a health insurance marketplace and technology platform, primarily serving Medicare-eligible individuals. The company leverages data-driven algorithms and proprietary technology to match consumers with suitable insurance plans, generating revenue through commissions from insurers. GoHealth differentiates itself through its multi-carrier platform, which offers a broad range of Medicare Advantage, Medicare Supplement, and other health insurance products. The company operates in a highly competitive and regulated sector, where its ability to scale efficiently and maintain strong insurer relationships is critical. GoHealth’s market position is bolstered by its digital-first approach, which streamlines the enrollment process and enhances consumer experience. However, the company faces challenges from regulatory changes, shifting insurer compensation models, and competition from both traditional brokers and emerging insurtech players. Its long-term success hinges on sustaining enrollment growth while optimizing marketing spend and operational efficiency.
GoHealth reported revenue of $798.9 million for FY 2024, reflecting its scale in the health insurance brokerage market. The company posted a net loss of $2.9 million, with diluted EPS of -$0.29, indicating ongoing profitability challenges. Operating cash flow was negative at $21.6 million, while capital expenditures totaled $13.7 million, suggesting continued investment in technology and infrastructure despite financial pressures.
The company’s negative earnings and operating cash flow highlight inefficiencies in converting revenue to profitability. High customer acquisition costs and reliance on insurer commissions may constrain earnings power. Capital efficiency remains a concern, as GoHealth balances growth investments with the need to achieve sustainable cash flow generation in a competitive and cyclical industry.
GoHealth’s balance sheet shows $40.9 million in cash and equivalents against $528 million in total debt, indicating significant leverage. The high debt load raises liquidity concerns, particularly given the company’s negative operating cash flow. Financial health depends on improving profitability and managing debt obligations amid uncertain enrollment and commission trends.
GoHealth’s growth is tied to Medicare enrollment trends and its ability to expand its technology-driven brokerage platform. The company does not pay dividends, reinvesting available cash into operations and growth initiatives. Future performance will depend on scaling its platform efficiently and adapting to regulatory and competitive dynamics in the health insurance market.
Market expectations for GoHealth appear muted, given its profitability challenges and leveraged balance sheet. Investors likely focus on the company’s ability to stabilize earnings and reduce debt. Valuation metrics may reflect skepticism about near-term turnaround prospects, with attention on operational execution and potential strategic shifts.
GoHealth’s proprietary technology and established insurer relationships provide a foundation for recovery, but execution risks remain high. The outlook depends on improving unit economics, reducing debt, and navigating regulatory headwinds. Success in these areas could position the company for sustainable growth, though near-term uncertainty persists.
Company filings (10-K), investor presentations
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |